Follow
Arianna Giacomini
Arianna Giacomini
Verified email at unibs.it
Title
Cited by
Cited by
Year
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach
M Presta, P Chiodelli, A Giacomini, M Rusnati, R Ronca
Pharmacology & therapeutics 179, 171-187, 2017
1672017
Long-pentraxin 3 derivative as a small-molecule FGF trap for cancer therapy
R Ronca, A Giacomini, E Di Salle, D Coltrini, K Pagano, L Ragona, ...
Cancer cell 28 (2), 225-239, 2015
1152015
Blocking the FGF/FGFR system as a⿿ two-compartment⿿ antiangiogenic/antitumor approach in cancer therapy
A Giacomini, P Chiodelli, S Matarazzo, M Rusnati, M Presta, R Ronca
Pharmacological research 107, 172-185, 2016
932016
Long pentraxin 3: A novel multifaceted player in cancer
A Giacomini, GC Ghedini, M Presta, R Ronca
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1869 (1), 53-63, 2018
912018
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis
R Ronca, A Giacomini, M Rusnati, M Presta
Expert opinion on therapeutic targets 19 (10), 1361-1377, 2015
872015
Long pentraxin-3 inhibits epithelial–mesenchymal transition in melanoma cells
R Ronca, E Di Salle, A Giacomini, D Leali, P Alessi, D Coltrini, C Ravelli, ...
Molecular cancer therapeutics 12 (12), 2760-2771, 2013
842013
Long pentraxin‐3 as an epithelial–stromal fibroblast growth factor‐targeting inhibitor in prostate cancer
R Ronca, P Alessi, D Coltrini, E Di Salle, A Giacomini, D Leali, M Corsini, ...
The Journal of pathology 230 (2), 228-238, 2013
742013
Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease
A Giacomini, M Ackermann, M Belleri, D Coltrini, B Nico, D Ribatti, ...
Angiogenesis 18, 499-510, 2015
442015
Human CD34+ cells engineered to express membrane-bound tumor necrosis factor–related apoptosis-inducing ligand target both tumor cells and tumor vasculature
C Lavazza, C Carlo-Stella, A Giacomini, L Cleris, M Righi, D Sia, ...
Blood, The Journal of the American Society of Hematology 115 (11), 2231-2240, 2010
422010
Sorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cells
C Carlo-Stella, SL Locatelli, A Giacomini, L Cleris, E Saba, M Righi, ...
PloS one 8 (4), e61603, 2013
402013
Antiangiogenic effects of N6‐isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation
S Pisanti, P Picardi, E Ciaglia, L Margarucci, R Ronca, A Giacomini, ...
The FASEB Journal 28 (3), 1132-1144, 2014
392014
Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy
M Belleri, R Ronca, D Coltrini, B Nico, D Ribatti, PL Poliani, A Giacomini, ...
Brain 136 (9), 2859-2875, 2013
392013
Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts
SL Locatelli, A Giacomini, A Guidetti, L Cleris, R Mortarini, A Anichini, ...
Leukemia 27 (8), 1677-1687, 2013
382013
Synthesis, structural elucidation, and biological evaluation of NSC12, an orally available fibroblast growth factor (FGF) ligand trap for the treatment of FGF-dependent lung tumors
R Castelli, A Giacomini, M Anselmi, N Bozza, F Vacondio, S Rivara, ...
Journal of Medicinal Chemistry 59 (10), 4651-4663, 2016
312016
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers
A Giacomini, S Matarazzo, K Pagano, L Ragona, S Rezzola, M Corsini, ...
Oncotarget 6 (15), 13790, 2015
302015
sTRAIL coupled to liposomes improves its pharmacokinetic profile and overcomes neuroblastoma tumour resistance in combination with Bortezomib
M Loi, P Becherini, L Emionite, A Giacomini, I Cossu, E Destefanis, ...
Journal of controlled release 192, 157-166, 2014
272014
Myeloablative doses of yttrium‐90‐ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia
A Guidetti, C Carlo‐Stella, M Ruella, R Miceli, L Devizzi, SL Locatelli, ...
Cancer 117 (22), 5074-5084, 2011
242011
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis
F Caccuri, R Ronca, AS Laimbacher, A Berenzi, N Steimberg, ...
Oncotarget 8 (27), 44533, 2017
182017
A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments
M Righi, A Giacomini, C Lavazza, D Sia, C Carlo-Stella, AM Gianni
Laboratory investigation 89 (9), 1063-1070, 2009
132009
D Quantification of Tumor Vasculature in Lymphoma Xenografts in NOD/SCID Mice Allows to Detect Differences among Vascular-Targeted Therapies
M Righi, A Giacomini, L Cleris, C Carlo-Stella
PloS one 8 (3), e59691, 2013
92013
The system can't perform the operation now. Try again later.
Articles 1–20